rxstat › Shortages › Apremilast

Apremilast shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Apremilast is in a widespread shortage in Canada. 2 of 3 reported products are affected. Manufacturers have not committed to a recovery date.

An anti-inflammatory medication used to treat psoriasis and psoriatic arthritis.

Products affected
2 / 3
In shortage since
Dec 9, 2025
Reports on file
4
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
APO-APREMILAST
30MG · TABLET · APOTEX INC
DIN 02538180 · since May 5, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
GLN-APREMILAST
30MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02518910 · since Dec 9, 2025, no end estimate · Disruption of the manufacture of the drug.
Resolved
APO-APREMILAST
30MG · TABLET · APOTEX INC
DIN 02538180 · ended Jan 30, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-APREMILAST
30MG · TABLET · AURO PHARMA INC
DIN 02524104 · ended Aug 28, 2024 · Demand increase for the drug.

What's happening

Apremilast is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC, GLENMARK PHARMACEUTICALS CANADA INC..

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Apremilast is classified under “IMMUNOSUPPRESSANTS” (ATC L04AA).

Recent changes

Common questions

What is Apremilast used for?

An anti-inflammatory medication used to treat psoriasis and psoriatic arthritis.

When will Apremilast be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Apremilast in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (immunosuppressants)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Abatacept (Orencia) No current shortage Azathioprine (Imuran) No current shortage Belimumab (Benlysta) No current shortage Etanercept (Rymti) No current shortage Ixekizumab (Taltz) No current shortage Mycophenolic Acid No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.